← All stocks

Pfizer Inc

PFEPharmaceuticalsLatest filing used: 2026-11-03Filings on SEC EDGAR ↗

Dividend grower

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$28.90

Nov 13, 2026

How we decide

Ten years of results

Revenue

$62.6B in FY2025, down 2% on the year before

FY2016: $52.8BFY2017: $52.5BFY2018: $40.8BFY2019: $40.9BFY2020: $41.7BFY2021: $81.3BFY2022: $101.2BFY2023: $59.6BFY2024: $63.6BFY2025: $62.6B$75B$150BFY16FY19FY22FY25$62.6B
Show as table
YearRevenue
FY2016$52.8B
FY2017$52.5B
FY2018$40.8B
FY2019$40.9B
FY2020$41.7B
FY2021$81.3B
FY2022$101.2B
FY2023$59.6B
FY2024$63.6B
FY2025$62.6B

Dividends per share

$1.72 a share in FY2025

FY2016: $1.22FY2017: $1.30FY2018: $1.38FY2019: $1.46FY2020: $1.53FY2021: $1.57FY2022: $1.61FY2023: $1.65FY2024: $1.69FY2025: $1.72$1$2FY16FY19FY22FY25$1.72
Show as table
YearDividends per share
FY2016$1.22
FY2017$1.30
FY2018$1.38
FY2019$1.46
FY2020$1.53
FY2021$1.57
FY2022$1.61
FY2023$1.65
FY2024$1.69
FY2025$1.72

Shares outstanding

Share count fell 7% over 9 years

FY2016: 6.16BFY2017: 6.06BFY2018: 5.98BFY2019: 5.67BFY2020: 5.63BFY2021: 5.71BFY2022: 5.73BFY2023: 5.71BFY2024: 5.70BFY2025: 5.71B04B8BFY16FY19FY22FY255.71B
Show as table
YearShares outstanding
FY20166.16B
FY20176.06B
FY20185.98B
FY20195.67B
FY20205.63B
FY20215.71B
FY20225.73B
FY20235.71B
FY20245.70B
FY20255.71B

No cash earnings in the filings.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-03. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.